336 related articles for article (PubMed ID: 23912896)
1. The multifaceted role of glial cells in amyotrophic lateral sclerosis.
Valori CF; Brambilla L; Martorana F; Rossi D
Cell Mol Life Sci; 2014 Jan; 71(2):287-97. PubMed ID: 23912896
[TBL] [Abstract][Full Text] [Related]
2. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis.
Laferriere F; Polymenidou M
Swiss Med Wkly; 2015; 145():w14054. PubMed ID: 25635517
[TBL] [Abstract][Full Text] [Related]
3. Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease.
Ito H; Fujita K; Nakamura M; Wate R; Kaneko S; Sasaki S; Yamane K; Suzuki N; Aoki M; Shibata N; Togashi S; Kawata A; Mochizuki Y; Mizutani T; Maruyama H; Hirano A; Takahashi R; Kawakami H; Kusaka H
Acta Neuropathol; 2011 Apr; 121(4):555-7. PubMed ID: 21327942
[No Abstract] [Full Text] [Related]
4. From nucleation to widespread propagation: A prion-like concept for ALS.
Maniecka Z; Polymenidou M
Virus Res; 2015 Sep; 207():94-105. PubMed ID: 25656065
[TBL] [Abstract][Full Text] [Related]
5. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism.
Keller BA; Volkening K; Droppelmann CA; Ang LC; Rademakers R; Strong MJ
Acta Neuropathol; 2012 Nov; 124(5):733-47. PubMed ID: 22941224
[TBL] [Abstract][Full Text] [Related]
6. A perspective on stem cell modeling of amyotrophic lateral sclerosis.
de Boer AS; Eggan K
Cell Cycle; 2015; 14(23):3679-88. PubMed ID: 26505672
[TBL] [Abstract][Full Text] [Related]
7. State of play in amyotrophic lateral sclerosis genetics.
Renton AE; Chiò A; Traynor BJ
Nat Neurosci; 2014 Jan; 17(1):17-23. PubMed ID: 24369373
[TBL] [Abstract][Full Text] [Related]
8. Mutations of optineurin in amyotrophic lateral sclerosis.
Maruyama H; Morino H; Ito H; Izumi Y; Kato H; Watanabe Y; Kinoshita Y; Kamada M; Nodera H; Suzuki H; Komure O; Matsuura S; Kobatake K; Morimoto N; Abe K; Suzuki N; Aoki M; Kawata A; Hirai T; Kato T; Ogasawara K; Hirano A; Takumi T; Kusaka H; Hagiwara K; Kaji R; Kawakami H
Nature; 2010 May; 465(7295):223-6. PubMed ID: 20428114
[TBL] [Abstract][Full Text] [Related]
9. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS.
Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; Atkin JD
Acta Neuropathol; 2015 Nov; 130(5):679-97. PubMed ID: 26298469
[TBL] [Abstract][Full Text] [Related]
10. Rodent Models of Amyotrophic Lateral Sclerosis.
Philips T; Rothstein JD
Curr Protoc Pharmacol; 2015 Jun; 69():5.67.1-5.67.21. PubMed ID: 26344214
[TBL] [Abstract][Full Text] [Related]
11. Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis.
Frakes AE; Ferraiuolo L; Haidet-Phillips AM; Schmelzer L; Braun L; Miranda CJ; Ladner KJ; Bevan AK; Foust KD; Godbout JP; Popovich PG; Guttridge DC; Kaspar BK
Neuron; 2014 Mar; 81(5):1009-1023. PubMed ID: 24607225
[TBL] [Abstract][Full Text] [Related]
12. Sporadic and hereditary amyotrophic lateral sclerosis (ALS).
Ajroud-Driss S; Siddique T
Biochim Biophys Acta; 2015 Apr; 1852(4):679-84. PubMed ID: 25193032
[TBL] [Abstract][Full Text] [Related]
13. Amyotrophic Lateral Sclerosis: Precise Diagnosis and Individualized Treatment.
Tao QQ; Wu ZY
Chin Med J (Engl); 2017 Oct; 130(19):2269-2272. PubMed ID: 28937029
[No Abstract] [Full Text] [Related]
14. CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model.
Matsumoto T; Imagama S; Hirano K; Ohgomori T; Natori T; Kobayashi K; Muramoto A; Ishiguro N; Kadomatsu K
Neurosci Lett; 2012 Jun; 520(1):115-20. PubMed ID: 22634473
[TBL] [Abstract][Full Text] [Related]
15. Using yeast models to probe the molecular basis of amyotrophic lateral sclerosis.
Bastow EL; Gourlay CW; Tuite MF
Biochem Soc Trans; 2011 Oct; 39(5):1482-7. PubMed ID: 21936838
[TBL] [Abstract][Full Text] [Related]
16. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
[TBL] [Abstract][Full Text] [Related]
17. Protein aggregation in amyotrophic lateral sclerosis.
Blokhuis AM; Groen EJ; Koppers M; van den Berg LH; Pasterkamp RJ
Acta Neuropathol; 2013 Jun; 125(6):777-94. PubMed ID: 23673820
[TBL] [Abstract][Full Text] [Related]
18. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
[TBL] [Abstract][Full Text] [Related]
19. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
[TBL] [Abstract][Full Text] [Related]
20. Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS.
Cook C; Petrucelli L
Neuron; 2019 Mar; 101(6):1057-1069. PubMed ID: 30897357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
